Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Primary and Secondary Prevention of Smoking Related Diseases With Low Dose CT Scan and Circulating Biomarkers, Coupled With Personalised Smoking Cessation Activity

NCT06451029 is registered in ClinicalTrials.gov with Scientific Institute San Raffaele as lead sponsor.

NCT NCT06451029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06451029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Primary and Secondary Prevention of Smoking Related Diseases With Low Dose CT Scan and Circulating Biomarkers, Coupled With Personalised Smoking Cessation Activity
Lead sponsor
Scientific Institute San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
January 11, 2022
Completion date
December 31, 2025
Enrollment
189 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung cancer screening, smoking cessation